$680.3 Million Worldwide CRISPR Technology Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets.com

After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 22.9% CAGR for the next 7-year period.\nThe U.S. Market is Estimated at $203.2 Million, While China is Forecast to Grow at 21.4% CAGR\nThe CRISPR Technology market in the U.S. is estimated at US$203.2 Million in the year 2020.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Thursday, May 13, 2021
Information
Tags: 
Health, General Health, Actuarial science, Compound annual growth rate, Mathematical finance
Geotags: 
JAPAN, US, EUROPE, CHINA, CANADA, GERMANY
⚠generated by AI ↴
Summary
Key Points: 
  • After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 22.9% CAGR for the next 7-year period.\nThe U.S. Market is Estimated at $203.2 Million, While China is Forecast to Grow at 21.4% CAGR\nThe CRISPR Technology market in the U.S. is estimated at US$203.2 Million in the year 2020.
  • China, the world\'s second largest economy, is forecast to reach a projected market size of US$474.7 Million by the year 2027 trailing a CAGR of 21.4% over the analysis period 2020 to 2027.
  • Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 19.7% and 18.6% respectively over the 2020-2027 period.
  • Within Europe, Germany is forecast to grow at approximately 15.2% CAGR.\n'


The "CRISPR Technology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for CRISPR Technology estimated at US$680.3 Million in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at a CAGR of 21.8% over the period 2020-2027.

Products, one of the segments analyzed in the report, is projected to record 21.1% CAGR and reach US$1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 22.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $203.2 Million, While China is Forecast to Grow at 21.4% CAGR

The CRISPR Technology market in the U.S. is estimated at US$203.2 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$474.7 Million by the year 2027 trailing a CAGR of 21.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 19.7% and 18.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.2% CAGR.

Select Competitors (Total 34 Featured):

  • Agilent Technologies
  • Cellecta, Inc.
  • GeneCopoeia, Inc.
  • GenScript
  • Horizon Discovery Group
  • Integrated DNA Technologies (IDT)
  • Merck KGaA
  • New England Biolabs
  • Origene Technologies, Inc.
  • Synthego Corporation

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • REST OF EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

IV. COMPETITION

  • Total Companies Profiled: 34

For more information about this report visit https://www.researchandmarkets.com/r/cywz8a

Copyright: 
Copyright Business Wire 2021